Molecular Biosensors Market - Growth, Trends, Forecast (2020 - 2025)

The market is segmented by Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors, Piezoelectric Biosensors), Application, and Geography.

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals. Molecular biosensors are, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread

In recent years, due to ti increasing prevalence of chronic diseases, demand for point-of-care diagnostics has increased. This has led to an increase in demand for molecular biosensors. The factors have resulted in increased adoption of the molecular biosensor, which has helped the market growth.

However, high costs involved in research and development and strict regulatory guidelines to by authorities dissuade many manufacturers to enter the market. This has hindered the growth rate of the market.

 

Scope of the Report

A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals and is, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis.

In the report, a detailed analysis of the market is provided. The market is evaluated by collating revenues generated across segments, categorized by Technology, Application, and Geography.

 

By Technology
Electrochemical Biosensors
Optical Biosensors
Thermal Biosensors
Others
By Application
Medical Diagnostics
Food and Beverages
Environment Safety
Defense and Security
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Electrochemical Biosensors is Expected to Dominate the Market

Electrochemical biosensors have emerged as reliable molecular sensing devices suitable for the detection of pathogens in liquid biopsies. Short assay time, simple handling, low cost, small sample requirement, the ibility of multiplexing and miniaturization and good performance in complex samples with minimal pre-treatments justify their increasing growing and suitability for POC applications. These biosensors are able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread.

Pathogens are microorganisms that cause infectious disease. Bacteria and viruses are the main pathogens. Bacteria release toxins, and viruses damage cells. White blood cells destroy pathogens by ingestion or producing antibodies against them and antitoxins to neutralize toxins. Recently, due to unhealthy living conditions, especially in developing and underdeveloped countries, the incidence of bacterial infection has increased. Even in developed countries like the United States, the incidence of campylobacter gram-negative bacteria infection increased from 12.82 in 2004 to 12.97 in 2009 to 13.29 in 2014, according to a 2016  report by the  Centers for Disease Control and Prevention.

Hence with increase in infection from pathogens, the demand for fast PoC diagnostics like electrochemical biosensors is expected to increase

To understand key trends, Download Sample Report

North America is Expected to Dominate the Market

The North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

To understand geography trends, Download Sample Report.

Competitive Landscape

Majority of the molecular biosensors are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic and Lifestyle Induced Diseases

      2. 4.2.2 Increasing Demand for Point of Care Testing

      3. 4.2.3 Increasing Application of Biosensors in Various Industries

    3. 4.3 Market Restraints

      1. 4.3.1 Strict Regulatory Requirements for Biosensors

      2. 4.3.2 High Cost Involved in Research and Development

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 Electrochemical Biosensors

      2. 5.1.2 Optical Biosensors

      3. 5.1.3 Thermal Biosensors

      4. 5.1.4 Others

    2. 5.2 By Application

      1. 5.2.1 Medical Diagnostics

      2. 5.2.2 Food and Beverages

      3. 5.2.3 Environment Safety

      4. 5.2.4 Defense and Security

      5. 5.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories Inc.

      2. 6.1.2 Dynamic Biosensors GmbH

      3. 6.1.3 Bio-Rad Laboratories Inc

      4. 6.1.4 F. Hoffmann La Roche

      5. 6.1.5 Johnson and Johnson

      6. 6.1.6 LifeSensors Inc.

      7. 6.1.7 Medtronic Inc.

      8. 6.1.8 Nova biomedical Corporation

      9. 6.1.9 Siemens Healthcare

      10. 6.1.10 Sysmex Corporation

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports